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Abstract
Background: The prevalence of cardiovascular disease is increasing. Improved treatment options increase
survival after an acute myocardial infarction or sudden cardiac arrest, although patients often have difficulty
adjusting and regaining control in daily life. In particular, patients who received an implantable cardioverter
defibrillator (ICD) experience physical and psychological problems. Interventions to enhance perceived control
and acceptance of the device are therefore necessary. This paper describes a small-scale study to explore the
feasibility and the possible benefits of a structured nurse- and peer-led self-management programme ('Chronic
Disease Self-Management Program' – CDSMP) among ICD patients.
Methods: Ten male ICD patients (mean age = 65.5 years) participated in a group programme, consisting of six
sessions, led by a team consisting of a nurse specialist and a patient with cardiovascular disease. Programme
feasibility was evaluated among patients and leaders by measuring performance of the intervention according to
protocol, attendance and adherence of the participating ICD patients, and patients' and leaders' opinions about
the programme. In addition, before and directly after attending the intervention, programme benefits (e.g.
perceived control, symptoms of anxiety and depression, and quality of life) were assessed.
Results: The programme was conducted largely according to protocol. Eight patients attended at least four
sessions, and adherence ranged from good to very good. On average, the patients reported to have benefited
very much from the programme, which they gave an overall report mark of 8.4. The leaders considered the
programme feasible as well. Furthermore, improvements were identified for general self-efficacy expectancies,
symptoms of anxiety, physical functioning, social functioning, role limitations due to physical problems, and pain.
Conclusion: This study suggests that a self-management programme led by a team consisting of a nurse specialist
and a patient with cardiovascular disease seems feasible according to both patients and leaders. The programme
may improve general self-efficacy expectancies, symptoms of anxiety, and quality of life (physical functioning, social
functioning, role limitations due to physical problems, and pain) as well. Further investigation of the programme's
effectiveness among a larger sample of ICD patients or other patient groups with cardiovascular disease, is
recommended.
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Background
Worldwide, chronic conditions in general and specifically
cardiovascular disease (CVD), are a major health burden
[1]. The prevalence of CVD is increasing because of
changed life expectancies, unhealthy lifestyles, and
improved treatment options [2,3]. Because of these
improved therapies, patients suffering from acute myocar-
dial infarction have a considerably higher chance of sur-
vival. A substantial number of CVD patients receive an
implantable cardioverter defibrillator (ICD), making it
one of the most important recent advanced therapies in
the prevention of sudden cardiac arrest due to life-threat-
ening arrhythmias [4,5].
Adjusting to the consequences of CVD and regaining con-
trol in daily life can often be difficult, particularly after
ICD implantation. Introducing a foreign body into the
heart may be considered a major life event; ICD patients
may be confronted with a changed body image, problems
of psychosocial adaptation, and reduced quality of life
[6]. In addition, symptoms of anxiety and depression after
implantation appear to be common among ICD patients,
affecting 24–87% and 24–33%, respectively, while 13–
38% suffer clinically significant anxiety disorders [7]. So,
although implantation may relieve much of the fear of
sudden death, it also introduces new fears, so that the
overall effect on psychological health is largely neutral [8].
Patients have to cope with the presence of a potentially
life-threatening condition (i.e. ventricular arrhythmias)
and the experience of potentially aversive treatment (i.e.
shocks). According to Sears and colleagues [7], patients
may increasingly limit their range of activities and inad-
vertently diminish their quality of life due to fear of
shocks. To deal with the perceived lack of control, the fun-
damental psychological challenge for ICD patients is to
derive perceived security from the ICD device [7,9]. Psy-
chological interventions to enhance perceived control and
acceptance of the device are therefore necessary [10]. A
recent review showed that only a few studies assessed the
effects of psychological interventions for ICD patients
[11]. In the majority of these studies, no significant effects
of these interventions were found, with exception of a
cognitive behavioural therapy intervention [12]. In the
majority of these studies, the lack of positive results may
be explained partly by the small sample sizes and possibly
also by the unstructured format of several of the interven-
tions [11].
Structured self-management programmes have been
developed by Lorig and colleagues since the early 1980s,
including the widely disseminated 'Chronic Disease Self-
Management Program' (CDSMP) [13-18]. The CDSMP is
a generic group-based self-management programme,
which is based on the principal assumption that patients
with various chronic diseases can learn from each other as
they have similar self-management problems and disease-
related tasks [14]. The CDSMP, which is generally led by
trained lay leaders, has been proved effective in several
randomised trials with 6 to 24 months of follow-up
[13,14,19]. It has been shown to significantly improve
exercise level and communication with physicians, and to
result in positive changes in health status and a reduction
of health care utilisation among heterogeneous groups of
patients with chronic conditions (including heart disease,
lung disease, stroke, and arthritis) [14,15]. Although the
CDSMP is originally developed for use in heterogeneous
patient groups, we expect that the programme is also very
well applicable in homogeneous patient groups such as
ICD patients. The advantages of a homogeneous patient
group may be that during the group process patients have
better opportunities to share their disease specific prob-
lems, and are more likely to function as role models for
each other. The CDSMP is based on Bandura's Social Cog-
nitive Theory [20] and incorporates modelling, skills mas-
tery, reinterpretation of symptoms, and social persuasion
to enhance self-efficacy expectancies [13,15]. In cardiac
samples, self-efficacy has been associated positively with
life style changes and adherence to exercise programs [21].
In addition, the Social Cognitive Theory framework has
been shown to be suitable for application to ICD patients
improving physical and psychological functioning [22].
As in ICD patients the success of the device implantation
may depend, in part, on the recipient's ability to adjust
psychologically to the device [23,24], it is therefore
important to assess the benefits of this self-management
programme for ICD patients.
Aim
This study presents the first exploration of the feasibility
and the possible benefits of a Dutch nurse- and peer-led
version of the structured CDSMP in a small group of ICD
patients. To integrate the programme into the Dutch
health care system, the Dutch version of the CDSMP
incorporates a leader team made up of a cardiac nurse spe-
cialist ('professional leader') and a CVD patient ('peer
leader'), instead of two lay leaders.
Methods
Design
A feasibility study with a one group pre-test/post-test
design was carried out in order to assess the feasibility and
the possible benefits of the programme.
Participants
In 2003, a total of 95 patients received an ICD at Univer-
sity Hospital Maastricht. Of this group, 63 patients living
in the three regions nearest the hospital were selected for
our study to improve attendance at the programme ses-
sions. Of these 63 patients, 37 persons were excluded due
to participation in other studies or because they were noBMC Nursing 2007, 6:6 http://www.biomedcentral.com/1472-6955/6/6
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longer treated at University Hospital Maastricht. This pro-
cedure resulted in 26 eligible ICD patients who all
received written information about the intervention and
the study. Ten ICD patients were able and willing to par-
ticipate in the study and attended the programme in the
period May – June 2004.
Intervention
The CDSMP consists of six weekly sessions, each lasting
two and a half hours, and emphasizes the patients' central
role and responsibility in managing their illness [13].
More specifically, patients learn three types of manage-
ment tasks to achieve a positive and active management
style: patients learn to deal with the medical management
of the disease (medical management); to maintain,
change and create new meaningful behaviours or life roles
(role management), and third, to deal with the emotional
consequences of having a chronic condition (emotional
management). Regaining a sense of control by learning
these three sets of tasks may improve quality of life in
patients with a chronic disease [15,25] and perhaps also
in CVD patients receiving ICD therapy.
Before the start of the study, the programme was trans-
lated into Dutch, including the book "Living a healthy life
with chronic conditions" [26], written as a reference source
for the material covered in the CDSMP. The patients
received this book during the first programme session.
Table 1 shows the CDSMP activities per session.
Although the CDSMP is originally led by two trained lay
leaders, we decided to conduct the programme using a
cardiac nurse specialist ('professional leader') and a
patient with cardiovascular disease ('peer leader'). The
choice for a nurse specialist was based on the fact that
nurse specialists appear to play an important role in pro-
moting self-care behaviour [27-30]. The CVD patient in
the programme acts as a chronic disease role model. Fur-
thermore, because of the exploratory approach of the
study, several pairs of leaders were trained. They led the
programme sessions in turns, in order to gain sufficient
insight in the feasibility of the programme. Before the
actual study started, three nurse specialists and four
patients received four days of training on the CDSMP pro-
tocol. The leaders were trained by one of the researchers
(author E.S.) and a cardiac nurse specialist from Univer-
sity Hospital Maastricht. Both had been instructed as mas-
ter trainers at Stanford University.
Data collection
Experiences with the programme
In order to gather information about the feasibility of the
programme, four process outcomes were measured by
structured evaluation forms: performance of the interven-
tion according to protocol, attendance and adherence of
the patients (i.e. patients' effort during the programme
sessions), and patients' and leaders' opinions about the
programme.
At the end of each session, the leaders described whether
the activities during that session had been carried out
according to protocol (i.e. the time limits for each activity
adhered to, no activities skipped or shortened, or other
training techniques used than required). In addition, the
Table 1: Contents of the CDSMP
Session 1
Activity 1 Introduction – Identifying common problems
Activity 2 Workshop overview and responsibilities
Activity 3 Differences between acute and chronic conditions
Activity 4 Introduction to cognitive symptom management
Activity 5 Introduction to action plans
Activity 6 Closing
Session 2
Activity 1 Feedback/problem-solving session
Activity 2 Dealing with emotions (anger, fear, frustration)
Activity 3 Introduction to exercise
Activity 4 Making an action plan
Activity 5 Closing
Session 3
Activity 1 Feedback/problem-solving session
Activity 2 Better breathing
Activity 3 Muscle relaxation
Activity 4 Fatigue management
Activity 5 Endurance exercise
Activity 6 Making an action plan
Activity 7 Closing
Session 4
Activity 1 Feedback/problem-solving/making an action plan
Activity 2 Healthy eating
Activity 3 Distraction
Activity 4 Advance directives for health care
Activity 5 Communication skills
Activity 6 Problem-solving
Activity 7 Closing
Session 5
Activity 1 Feedback/problem-solving/making an action plan
Activity 2 Medication usage
Activity 3 Making informed treatment decisions
Activity 4 Depression management
Activity 5 Self-talk
Activity 6 Guided imagery
Activity 7 Closing
Session 6
Activity 1 Feedback/problem-solving
Activity 2 Informing the health care team
Activity 3 Working with your health care professional
Activity 4 Looking back and planning for the future
Activity 5 ClosingBMC Nursing 2007, 6:6 http://www.biomedcentral.com/1472-6955/6/6
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leaders recorded patients' attendance and adherence on a
structured form. The overall level of patients' adherence
with the programme activities was assessed by the leaders
per session using a five-point scale (very good – very bad).
The patients' opinions about the programme were
assessed after each session and directly after completion of
the programme, using structured forms. The patients were
asked to give their opinion about the relevance to their
personal situation of each session (four-point scale; not at
all relevant – very relevant) and to give a general report
mark for the session (10-point scale; 1 to 10). Directly
after completion of the programme, patients were asked
to what extent they had benefited from it and which parts
they had or had not appreciated. In addition, they were
asked to assess the quality of the nurse specialist and the
CVD patient as leaders (on a five-point scale from 'very
good' to 'very bad'), to give overall report marks for the
leaders and for the programme (10-point scales; 1 to 10),
and to suggest possible improvements to the CDSMP.
Experiences were assessed only of patients who attended
at least three sessions. The leaders' opinion about the pro-
gramme was assessed directly after completion of the six
sessions by means of two structured group interviews: one
for the professional leaders and one for the peer leaders.
At these meetings, the leaders evaluated the protocol's fea-
sibility and the cooperation with the co-leader.
Programme benefits
In order to assess the possible benefits of the programme,
we measured self-efficacy expectancies, perceived control,
symptoms of anxiety and depression, and quality of life at
baseline and six weeks follow-up. Socio-demographic var-
iables and co-morbidity were assessed once, at baseline.
Self-efficacy expectancies were measured with the 'General
Self-Efficacy Scale' (GSES) [31]. Perceived control, or mas-
tery, was measured by means of the Dutch version of the
seven-item scale developed by Pearlin and Schooler [32].
Symptoms of anxiety and depression were measured with
the Dutch version of the 'Hospital Anxiety and Depression
Scale' (HADS) [33] which is considered to be unbiased by
coexisting general medical conditions [34]. Health-related
quality of life was assessed using eight of the nine sub-
scales of the 'RAND 36-item Health Survey' (RAND-36)
[35]: 'physical functioning', 'social functioning', 'role lim-
itations (due to physical problems)', 'role limitations (due
to emotional problems)', 'mental health', 'vitality', 'pain',
and 'general health perception'. The psychometric proper-
ties of the Dutch versions of the GSES, perceived control
scale, the HADS, and the RAND-36 were shown to be sat-
isfactory in previous studies [34,36-39].
Socio-demographics (gender, age, marital state, living
arrangement, educational level, and working situation)
and co-morbidity (the presence of 19 chronic medical
conditions) were assessed at baseline. Data were collected
by self-administered questionnaires and telephone inter-
views. The telephone interviews were conducted inde-
pendently by trained interviewers.
Ethical considerations
The Medical Ethics Committee of Maastricht University/
University Hospital Maastricht granted approval to con-
duct this study. All ICD patients were fully informed
about the purpose and content of the study. Participation
was voluntary and written consent was obtained prior to
the measurement at baseline (May 2004). The investiga-
tion conformed with the principles outlined in the Decla-
ration of Helsinki [40].
Data analysis
The data with respect to the experiences with the pro-
gramme were analysed in a descriptive way. To assess pos-
sible benefits for the ICD patients with respect to the
outcome measures, means and standard deviations at
baseline and at follow-up were computed. SPSS for Win-
dows, version 12.0.1 was used.
Results
Patient characteristics
Patients' mean age was 65.5 years (SD = 7.9) and ranged
from 50 to 76. All patients were male. The majority of
patients did not live alone (n = 7), had a fairly high level
of education (six patients had attended first stage of terti-
ary education) and were not employed (n = 8). The two
patients with employment worked at least 32 hours per
week. Mean time with the ICD was 8.3 months (range: 5–
15 months) before inclusion in the study. The majority of
the patients had a primary diagnosis of coronary artery
disease (n = 8), of whom two patients had been resusci-
tated prior to ICD implantation because of ventricular
arrhythmias. Patients' mean left ventricular ejection frac-
tion was 32% (range: 20–53%), of whom the majority
had suffered from at least one myocardial infarction prior
to ICD implantation (n = 9) and experienced New York
Heart Association (NYHA) Class II-III symptoms based on
results of exercise tests (n = 8). All patients had received
medical treatment for their heart condition in the preced-
ing 12 months. With regard to shock history, two patients
had experienced shocks in the period from implantation
to inclusion in the study; one patient had experienced two
shocks, the other patient had experienced an electrical
storm of three shocks. Regarding co-morbidity, five
patients reported no co-morbid chronic conditions, while
the other five patients had received medical help in the
preceding 12 months for at least one co-morbid chronic
condition.BMC Nursing 2007, 6:6 http://www.biomedcentral.com/1472-6955/6/6
Page 5 of 8
(page number not for citation purposes)
Programme feasibility
Performance according to protocol
The leaders stated that each session was carried out largely
according to protocol. Only minor protocol deviations
were reported (i.e. spending more time on a topic than
planned) as a result of problems with 'action planning'
and 'problem solving' (first activity, session two and five).
This was due to an imperfect match between the level of
some of the action plans and the patients' daily activities.
Also, the activities 'advance directives for health care' and
'communication skills' (session four) overran their time
within the session, because these activities were appraised
as difficult topics to deal with.
Patients' attendance and adherence
With regard to the attendance of the ten patients, the lead-
ers reported that one person withdrew from the pro-
gramme after the first session because the programme did
not meet his expectations. One patient could only attend
the first two sessions, because of hospitalisation for an
ICD device problem. The eight remaining patients
attended at least four sessions; one person could not
attend the first two sessions because of interference with
his work schedule, two persons were absent once due to
other appointments, and five persons attended all ses-
sions. The adherence per session and overall adherence
was 'good' to 'very good', according to the leaders.
Patients' opinion about the CDSMP
The patients appraised the programme as 'rather relevant'
to 'very relevant' and this opinion hardly differed for the
individual sessions. The second and the last sessions were
appreciated most by all patients. In the second session, all
activities were appreciated equally: from 'feedback/prob-
lem-solving session', 'dealing with emotions', 'introduc-
tion to exercise', and 'making an action plan' to the
opportunity to exchange personal experiences in that par-
ticular session. In the sixth session, 'working with your
health care professional' was considered the most impor-
tant activity, together with action planning in the activity
'looking back and planning for the future'. The report
marks per session showed that patients' overall opinion
about the programme was positive; the report marks
ranged from 7.6 (first session) to 8.3 (second session).
Seven of the eight patients filled in the evaluation form at
the end of the programme. On average, they reported to
have 'benefited very much' from the programme and the
overall report mark for the programme was 8.4. According
to the patients, the best programme activities were: 'mak-
ing an action plan' and 'problem-solving', cognitive symp-
tom management techniques (e.g. 'better breathing' and
'muscle relaxation'), 'dealing with emotions', and
'advance directives for health care'/'making informed
treatments decisions'. As regards the leaders, the ICD
patients generally evaluated them as 'good', with the pro-
fessional leader getting a higher score (report mark: 8.5)
than the peer leader (report mark: 7.4). The fact that one
of the leaders was a patient with cardiovascular disease
had no added value for three patients. Finally, the patients
made some suggestions for improvement of the CDSMP:
three patients recommended discussing more ICD-spe-
cific subjects (e.g. ICD technology) or paying more atten-
tion to ICD-specific problems in daily life.
Leaders' opinion about the CDSMP
The leaders (n = 8) considered the programme to be feasi-
ble. Yet they sometimes found it difficult to carry out the
programme exactly according to protocol (in particular,
the activities 'making an action plan', 'problem-solving',
and 'advance directives for health care'). Furthermore, the
peer leaders experienced some role ambiguity and had
some difficulties with modelling, which sometimes
resulted in the professional leader interfering or taking
over parts of the peer leader's activities.
Programme benefits
As table 2 shows, the mean scores improved at follow-up,
except for three subscales of the RAND-36 (vitality, gen-
eral perceived health, and role limitations due to emo-
tional problems). The largest differences in mean scores at
baseline and at follow-up were found for general self-effi-
cacy expectancies, symptoms of anxiety, and four RAND-
36 subscales: physical functioning, social functioning,
role limitations due to physical problems, and pain.
Discussion
From this feasibility study we learned that Lorig's struc-
tured self-management programme is applicable in a
homogeneous group of ICD patients. The CDSMP was
feasible according to patients and leaders. The patients
appraised the programme as relevant and gave an overall
report mark of 8.4. Furthermore, eight of the ten patients
attended at least four sessions of the programme and only
minor deviations from the protocol were reported. How-
ever, the leaders experienced some role ambiguity. This
may be due to the fact that the CDSMP protocol does not
include specific instructions for dividing the activities
between the two leaders. Adding specific instructions in
the protocol is therefore recommended, in order to
diminish this experienced role ambiguity. Furthermore,
becoming more experienced with the programme in prac-
tice may probably decrease role ambiguity as well. Next to
the applicability of the programme, the CDSMP seemed
to positively influence general self-efficacy expectancies,
symptoms of anxiety, physical functioning, social func-
tioning, role limitations due to physical problems, and
pain. Although obviously our small-scale approach does
not allow us to come to final conclusions regarding theBMC Nursing 2007, 6:6 http://www.biomedcentral.com/1472-6955/6/6
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effectiveness of the programme, our findings seem prom-
ising.
Future research
This study presented the first exploration of the feasibility
and the possible benefits of the CDSMP among ICD
patients. Based on the results of this study, we recom-
mend further investigation of the feasibility and effective-
ness of the CDSMP among a larger sample of ICD patients
or other CVD patient groups. Because of the exploratory
approach of the study, several pairs of leaders led the pro-
gramme sessions in turns, in order to gain sufficient
insight in the feasibility of the programme. Obviously, it
is recommended that in future projects each CDSMP class
is led by one team of leaders to guarantee continuity of the
programme. The turning pairs of leaders might have inter-
fered at some level with the peer leaders' task to be a suc-
cessful role model, as they could not optimally share
information based on their own experiences with the
patients in the group. However, to assure continuity of the
process for the patients, after each session a structured
report of that session was made by the professional leader
to inform the other leaders about the group's progress.
The fact that some of the patients considered the role of
the CVD patient leader as of minor value for the group
process might be explained by this discontinuity in lead-
ership.
In the present study, the programme was led by a cardiac
nurse specialist and a peer leader (i.e. a CVD patient),
instead of two trained lay leaders. This adaptation was
made in order to facilitate implementation in regular
health care in the Netherlands and to control continuity
of the programme if the peer leader should experience
physical problems due to the disease. Both professional
and peer leaders were positive about leading the sessions
together. The professional leader could support the peer
leader in conducting the programme, where the peer
leader could discuss personal experiences with the disease
during the sessions. Therefore, in future projects a combi-
nation of a professional leader and a peer leader per
CDSMP class seems to be a good alternative to a team of
two lay leaders. However, the final choice for the most
appropriate composition of the teams is dependent on the
setting in which it is going to be implemented.
Finally, in addition to assessing the effects of the pro-
gramme among ICD patients, future studies could also
study the effectiveness of the programme among partners
of patients, as they experience physical and psychosocial
problems as well in the caring process [41]. The CDSMP
protocol allows partners of patients with chronic condi-
tions to attend the programme, though for this feasibility
study we decided not to invite partners for logistic rea-
sons. In addition, future research should also assess
whether the intervention positively influences health care
utilisation in terms of visits to the outpatient clinic or hos-
pitalisation days.
Conclusion
The results of this study suggest that a group-based self-
management programme led by a team consisting of a
nurse specialist and a CVD patient is feasible for use
among ICD patients. In summary, we may conclude that
the intervention was generally performed according to
protocol, that the patients' attendance and adherence
Table 2: Means and standard deviations at baseline and follow-up (n = 10)
At baseline At follow-up (6 weeks)
Mean SD Mean SD
General self-efficacy expectancies* [16–80] 65.0 9.6 69.8 5.7
Perceived control* [7–35] 27.1 4.1 28.1 2.5
HADS** [0-21]
Symptoms of anxiety 5.1 3.4 3.7 2.4
Symptoms of depression 3.9 3.7 2.9 3.1
RAND-36* [0–100]
Physical functioning 66.0 17.4 72.8 22.5
Social functioning 75.0 22.5 84.7 25.6
Role limitations (physical problem) 50.0 48.4 69.4 42.9
Role limitations (emotional problem) 74.1 40.1 70.4 45.5
Mental health 79.6 13.6 82.7 13.9
Vitality 63.9 22.6 63.9 18.8
Pain 80.5 22.0 86.6 20.3
General health perception 56.7 19.5 56.7 22.9
* Higher scores indicate better functioning
** Higher scores indicate poorer functioning
Score between brackets refer to the theoretical range (underlined scores indicate most favourable scores)BMC Nursing 2007, 6:6 http://www.biomedcentral.com/1472-6955/6/6
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were high, and that the opinion of both patients and lead-
ers was positive. The experience of running the interven-
tion can therefore be concerned as satisfactory.
Furthermore, attending the CDSMP may positively influ-
ence general self-efficacy expectancies, symptoms of anxi-
ety, physical functioning, social functioning, role
limitations due to physical problems, and pain. As the
small-scale approach of this study did not allow testing for
statistical inferences, conclusions derived from this study
should be taken with some caution. Therefore, we recom-
mend assessing the effectiveness of the programme
among a larger sample of ICD patients or other CVD
patient groups in a randomised controlled trial.
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